Nikolaos P. Nanis - 09 Aug 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: Chief Technology Officer
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol: TDOC
Transactions as of: 09 Aug 2024
Net transactions value: -$1,470
Form type: 4
Filing time: 13 Aug 2024, 16:16:14 UTC
Previous filing: 02 Jul 2024
Next filing: 04 Sep 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Options Exercise		+568	+0.78%		73,794	09 Aug 2024	Direct	F1
transaction	TDOC	Common Stock	Sale	$1,470	-206	-0.28%	$7.14	73,588	12 Aug 2024	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-568	-100%	$0.000000^*	0	09 Aug 2024	Common Stock	568		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2	Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3	On August 10, 2021, the reporting person was granted 1,703 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.